Collaborative working with the NHS

Roche has successfully worked and continues to work alongside national, regional and local NHS organisations to support and implement developments in healthcare delivery for the benefit of UK patients.
At Roche, we firmly believe that better patient care can be achieved through collaborative working with the NHS. The ABPI Code of Practice defines ‘Collaborative Working with Organisations’ as work which either enhances patient care or is for the benefit of patients or alternatively benefits the NHS and, as a minimum, maintains patient care, and must be carried out in a manner compatible with the Code.

Collaborative working is generally between one or more pharmaceutical companies, healthcare organisations and other organisations. 

Joint working is a limited form of collaborative working, and describes work between one or more pharmaceutical companies and the NHS and others, is patient-centred and, the key defining point that separates it from collaborative working, is that joint working is always for the benefit of patients. 

Below is a list of collaborative working projects Roche is currently involved in. Click on the Executive Summary links below to learn more.

M-GB-00011736 Date of Preparation March 2023


Test and Treat Influenza Pathway Optimisation Pilot Project: Phase TwoTest and Treat Influenza Pathway Optimisation Pilot Project: Phase OneMultiple Sclerosis (MS) Hospital Episode Statistics (HES) Data DashboardThe Christie NHS Trust Programme ManagementThe Primary Care Breast Pain ClinicHuntington’s Disease (HD) Executive SummaryHuntington's Disease (HD) Project ReportEuropean Network for Innovative Treatment Evaluation for Breast CancerGOSH: Developing Clinical Informatics Using Real World Data Towards Personalised HealthcareCo-creation of Breast Cancer Patient Information VideosResearching Barriers to Clinical Trial Recruitment in Minority Ethnic PatientsInnovative Cancer Referral PathwaysBiomarker Pathway Pilot - Early detection of Alzheimer's DiseaseImplementing a novel multidisciplinary team (MDT) approach for the elderly Non-Hodgkin’s Lymphoma (NHL) patientEvaluating the impact of digital patient support materials on the breast cancer pathwayIncreasing representation and improving the experience of ethnic minority patients in breast cancer clinical trialsPilot Project of DATA-CAN's Real-Time Data NetworkNational Optimal Lung Cancer Pathway Analysis Model (NOLCP model)Use of AI & RWD to understand visual & anatomical outcomes in DMOSouth West (Peninsula) Multiple Sclerosis Regional MDT Project

This website contains information on products which is targeted to a wide range of audiences and could contain product details or information otherwise not accessible or valid in your country. Please be aware that we do not take any responsibility for accessing such information which may not comply with any legal process, regulation, registration or usage in the country of your origin.

ContactLocationsOur medicinesOur role in pharmaOur role in testing & diagnosticsRoche careersStoriesPrivacy policyTerms & ConditionsModern Slavery Act